Equity (Details Narrative) - USD ($) |
1 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Apr. 03, 2023 |
Aug. 05, 2022 |
Mar. 08, 2022 |
Jul. 31, 2020 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 03, 2023 |
|
Stock issued during period shares acquisitions | 791,667 | |||||||
Original prinicipal amount | $ 1,000,000.00 | |||||||
Annual interest rate | 7.00% | |||||||
Conversion price per share | $ 1.82 | $ 1.82 | ||||||
Stock price | $ 1.82 | |||||||
Ordinary shares issued | 549,451 | |||||||
Ordinary shares par value per share | $ 0.0002 | $ 0.0002 | $ 0.0002 | |||||
Conversion amount | $ 1,000,000.00 | |||||||
Additional paid in capital into common stock | $ 110 | |||||||
Number of warrants issued | 150,000 | |||||||
Warrants to purchase ordinary shares | 150,000 | |||||||
Exercise price of warrants | $ 6.00 | |||||||
Number of warrants issued | $ 10,000,000 | |||||||
Number of warrants exercised | 0 | |||||||
Scenario One [Member] | ||||||||
Exercise price of warrants | $ 1.80 | |||||||
Exercise price of warrants | $ 4,000,000 | |||||||
Scenario Two [Member] | ||||||||
Exercise price of warrants | $ 2.50 | |||||||
Exercise price of warrants | $ 7,000,000 | |||||||
Scenario Three [Member] | ||||||||
Exercise price of warrants | $ 3.00 | |||||||
Exercise price of warrants | $ 10,000,000 |
X | ||||||||||
- Definition Class of warrant or right exercised. No definition available.
|
X | ||||||||||
- Definition Class of warrant or right issued. No definition available.
|
X | ||||||||||
- Definition Class of warrant or right maximum aggregate exercises. No definition available.
|
X | ||||||||||
- Definition Class of warrant or right maximum exercises without prior consent. No definition available.
|
X | ||||||||||
- Definition Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|